Form 4 for PRQR ProQR Therapeutics N.V.
Accepted 2026-07-13 08:00:05 ET · period of report 2026-07-09 · accession 0001104659-26-082890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-13 08:00 | 2026-07-09 | PRQR | de Boer Daniel Anton | CEO, Dir | P - Purchase | $1.74 | +150.0K | 300.0K | +100% | +$261.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-09 | P | A | 150,000 | $1.74 | 300,000 | D | — | — |